戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 in our studies expresses high levels of this angiogenic growth factor.
2  and can be reversed by administration of an angiogenic growth factor.
3 y to treatment groups with either placebo or angiogenic growth factor.
4 endothelial cell migration in response to an angiogenic growth factor.
5 roviding direct evidence for GRO-alpha as an angiogenic growth factor.
6 r endothelial growth factor (VEGF), a potent angiogenic growth factor.
7 esses, and 2) exogenous focal delivery of an angiogenic growth factor.
8 l injury when administered in the absence of angiogenic growth factor.
9 eration of EPCs or secondary to secretion of angiogenic growth factors.
10 e and competing for the HS-binding domain of angiogenic growth factors.
11 een linked in vivo to enhanced expression of angiogenic growth factors.
12 ne kinase pathway, increasing the amounts of angiogenic growth factors.
13  likely to be associated with the release of angiogenic growth factors.
14 ivity but also stimulating the expression of angiogenic growth factors.
15 scular endothelium, which in turn depends on angiogenic growth factors.
16 ularly considering the multifaceted roles of angiogenic growth factors.
17 round spiral arteries and secrete a range of angiogenic growth factors.
18 duced angiogenesis via modulation of several angiogenic growth factors.
19 is was driven by sphingosine 1-phosphate and angiogenic growth factors.
20 a" reveals increased levels of proliferative/angiogenic growth factors.
21 responses of the local vascular cells to the angiogenic growth factors.
22 t gliomas and linked to RNA stabilization of angiogenic growth factors.
23 C formation and also inhibited expression of angiogenic growth factors.
24 eading and enhances migration in response to angiogenic growth factors.
25 xercise showed similar secretion patterns of angiogenic growth factors.
26 onplants comparable with that induced by the angiogenic growth factors.
27 ss osteogenic potential and produce numerous angiogenic growth factors.
28 omoting macrophages and direct inhibition of angiogenic growth factors.
29                  Activity of alternative pro-angiogenic growth factors, acting via RTK or G-protein c
30 was to determine whether SMOC-2 can modulate angiogenic growth factor activity and angiogenesis.
31           Thymidine phosphorylase (TP) is an angiogenic growth factor and a target for anticancer dru
32 ulation of Notch/Delta gene expression by an angiogenic growth factor and insight into the critical r
33 there is growing evidence of an imbalance in angiogenic growth factors and abnormal placentation.
34 proliferative neoplasm strictly dependent on angiogenic growth factors and cytokines and invariably a
35 ells, namely, macrophages, induces potential angiogenic growth factors and cytokines which contribute
36 potently inhibited heparanase and HS-binding angiogenic growth factors and displayed improved antitum
37 dothelial hyporesponsiveness to prototypical angiogenic growth factors and eNOS agonists, underlies v
38                                          Pro-angiogenic growth factors and enzymes up-regulated durin
39 hains of proteoglycan and releasing HS-bound angiogenic growth factors and facilitates tumor invasion
40 , extracted from a mouse sarcoma, is rich in angiogenic growth factors and has been shown to support
41  The 3DFC contains viable cells that secrete angiogenic growth factors and has previously been shown
42 teriogenesis and increased the expression of angiogenic growth factors and hypoxia-inducible factor-1
43 tained expression of labile genes, including angiogenic growth factors and immunosuppressive cytokine
44  with subsequently reduced concentrations of angiogenic growth factors and increased placental debris
45 agenesis involves the paracrine secretion of angiogenic growth factors and proinflammatory molecules
46 angiogenic phenotype that expressed multiple angiogenic growth factors and proteinases, such as macro
47 is by controlling the expression of multiple angiogenic growth factors and that adenovirus-mediated e
48 crovessels and that disordered expression of angiogenic growth factors and their receptors may contri
49                                              Angiogenic growth factors and their receptors, such as b
50               Allogeneic stimulation induces angiogenic growth factors and TSP-1 in T cells.
51 est a potential negative interaction between angiogenic growth factors and vascular cells; their use
52 tein tyrosine phosphorylation, production of angiogenic growth factors, and activation of signal prot
53 EMPs), circulating endothelial cells (CECs), angiogenic growth factors, and endothelial progenitor ce
54 nes are up-regulated in response to hypoxia, angiogenic growth factors, and signals regulating capill
55  tyrosine phosphorylation, the production of angiogenic growth factors, and the activation of signal
56                                          The angiogenic growth factor angiopoietin 2 (Ang2) destabili
57 GF-2), as well as smaller increases in other angiogenic growth factors (angiopoietin-2, thrombopoieti
58                                         Many angiogenic growth factors are regulated by hypoxia-induc
59 also detected in perinecrotic areas in which angiogenic growth factors are up-regulated.
60                                              Angiogenic growth factor assays revealed a distinct incr
61 f these fragments exceeded that of the known angiogenic growth factor, basic fibroblast growth factor
62                         VEGF is unique among angiogenic growth factors because it disrupts endothelia
63 s produced placenta growth factor (PlGF), an angiogenic growth factor belonging to the vascular endot
64                                          The angiogenic growth factor bFGF can be incorporated into d
65 001) in response to the administration of an angiogenic growth factor but not to placebo.
66 onuclear cells and the secretion of multiple angiogenic growth factors by CACs was determined.
67 c allografts may alter vascular responses to angiogenic growth factors by inhibiting angiogenesis and
68      Preclinical studies have indicated that angiogenic growth factors can stimulate the development
69 ellular matrix (FDM) is a novel platform for angiogenic growth factor delivery and that FDM-mediated
70 h has long been considered to be dictated by angiogenic growth factors (eg, vascular endothelial grow
71 ratinocytes and dermal fibroblasts, promoted angiogenic growth factor expression and angiogenesis in
72 of hypoxia-inducible factor-1alpha but lower angiogenic growth factor expression, higher expression o
73 arization by a mechanism involving increased angiogenic growth factor expression.
74 ion, suggesting its potential involvement in angiogenic growth factor expression.
75 Ges function is sufficient to substitute for angiogenic growth factor/extracellular matrix (ECM) sign
76 mising, FUS-based method of delivering a pro-angiogenic growth factor for stimulating angiogenesis an
77 esis is in part mediated by the secretion of angiogenic growth factors from myocytes in response to h
78 o suggest that ocular pathology is a risk of angiogenic growth factor gene transfer.
79  proliferation were measured with or without angiogenic growth factors (GFs).
80          Pathways implicate neurotrophic and angiogenic growth factors, gonadal hormone receptors, an
81 ers of the VEGF and Angiopoietin families of angiogenic growth factors has been linked to haemorrhagi
82                                          Pro-angiogenic growth factors have been studied as potential
83       Although the effects of overexpressing angiogenic growth factors have been studied in inducing
84 s suggest that ADSC secretome, enriched with angiogenic growth factors, holds strong potential for fa
85 ompetent to respond to an available level of angiogenic growth factors, however, may potentially limi
86 the ischemic myocardium using genes encoding angiogenic growth factors; however, randomized, double-b
87              These results indicate that the angiogenic growth factor, IGF-1, can regulate RUNX2 DNA
88 odermal tumors and described as an essential angiogenic growth factor in choriocarcinoma and melanoma
89 sed the levels of inflammatory cytokines and angiogenic growth factors in a dynamic and time dependen
90 owever, there was no change in the levels of angiogenic growth factors in comparison to tumors grown
91 nd clinical benefits with gene therapy using angiogenic growth factors in myocardial ischaemia.
92 y that new blood vessel formation induced by angiogenic growth factors in onplants placed on the chor
93 ympathetic nerves regulate the expression of angiogenic growth factors in rat retina.
94 ogical process to control bioavailability of angiogenic growth factors in the cornea.
95      Indeed, SPP synergized with polypeptide angiogenic growth factors in the formation of mature neo
96  the hypothesis that there is an increase in angiogenic growth factors in the pulp of orthodontically
97  To address these challenges, we upregulated angiogenic growth factors in the secretome from adipose-
98                    Despite the expression of angiogenic growth factors in transplanted hearts, neoves
99  neovascularization and on the expression of angiogenic growth factors in vascular endothelial cells.
100 oglycan of the vascular ECM, bind and signal angiogenic growth factors, including fibroblast growth f
101 ll-cell adhesion, inflammatory cytokine- and angiogenic growth factor-induced signals impinge on the
102        We recently described how miR-132, an angiogenic growth factor inducible microRNA in the endot
103                 The alteration in balance of angiogenic growth factors is mediated by both macrophage
104                                     bFGF, an angiogenic growth factor, is currently the subject of a
105     Angiogenin, a 14-kDa multifunctional pro-angiogenic growth factor, is upregulated in several type
106 cular endothelial growth factor (VEGF) is an angiogenic growth factor known to be up-regulated in isc
107                        The response to serum/angiogenic growth factors mapped to a 38-bp region of th
108 lso some evidence that biochemical assays of angiogenic growth factors may offer similar potential as
109 K1/2 when ECs were stimulated with other pro-angiogenic growth factors, namely fibroblast growth fact
110                               Alterations in angiogenic growth factors occur in cardiovascular diseas
111 his study indicates that DNAzymes, targeting angiogenic growth factors of tumors, show promise as ant
112                                 Injection of angiogenic growth factors often produces unstable and ab
113 To evaluate the effect of angiopoietin-1, an angiogenic growth factor, on lung capillary leakage and
114 om nonpregnant myometrium were cultured with angiogenic growth factors or conditioned medium (CM) fro
115 hese tumors do not depend entirely on either angiogenic growth factors or on neighboring endothelia t
116 utic revascularization with either exogenous angiogenic growth factors or vascular cells has yet to d
117 upport the notion that the administration of angiogenic growth factors, per se, is sufficient to stim
118              We previously reported that the angiogenic growth factor pleiotrophin (PTN) coaxes monoc
119 ith a regulatable expression of the secreted angiogenic growth factor PR39 in cardiomyocytes.
120                                              Angiogenic growth factors promote alveolar growth and co
121 er oligosaccharides, allowing for release of angiogenic growth factors promoting tumor development an
122  membranes were examined by Western blot for angiogenic growth factor receptor expression from 1 to 1
123 aluated for the spatiotemporal expression of angiogenic growth factor receptors on endothelial cell (
124 diac myocytes that induces the expression of angiogenic growth factors (see the related article begin
125                                              Angiogenic growth factor-stimulated cells exhibit substa
126 ease pellets are prepared by mixing purified angiogenic growth factors such as basic fibroblast growt
127 is-dependent, and an increased production of angiogenic growth factors such as vascular endothelial g
128 tors, which mediate the hypoxic induction of angiogenic growth factors such as vascular endothelial g
129                          FAK is activated by angiogenic growth factors, such as insulin-like growth f
130  mediates the stimulatory actions of several angiogenic growth factors, such as pleiotrophin (PTN).
131  expression on ECs was enhanced by promotive angiogenic growth factors, such as vascular endothelial
132  the consequences of diminished signaling by angiogenic growth factors, such as VEGF and FGF.
133 ignaling controls both fiber hypertrophy and angiogenic growth factor synthesis, illustrating a mecha
134 e directions regarding bevacizumab and other angiogenic growth factor-targeted therapeutics.
135 atocyte growth factor (scatter factor) is an angiogenic growth factor that binds to its cellular tran
136 al growth factor (VEGF) is a multifunctional angiogenic growth factor that is a primary stimulant of
137 cular endothelial growth factor (VEGF) is an angiogenic growth factor that is a primary stimulant of
138 ave identified Emc10 as a previously unknown angiogenic growth factor that is produced by bone marrow
139                 Angiopoietin-1 (Ang-1) is an angiogenic growth factor that promotes the chemotaxis of
140                    Scatter factor (SF) is an angiogenic growth factor that stimulates motility and in
141 r angiogenesis is mediated by tumor-secreted angiogenic growth factors that interact with their surfa
142 growth factor 165 (VEGF(165)) are potent pro-angiogenic growth factors that play a pivotal role in tu
143                     Here, we have shown that angiogenic growth factors that stimulate endothelial cel
144 collateral vessels in ischemic tissues using angiogenic growth factors (therapeutic angiogenesis) is
145                     The rapid development of angiogenic growth factor therapy for patients with advan
146 ization may be a generic requirement for pro-angiogenic growth factors to activate ERK1/2 signaling i
147            Controlled delivery approaches of angiogenic growth factors used adjunctively with GBR may
148 r necrosis factor-alpha to production of the angiogenic growth factor vascular endothelial growth fac
149 ignificant proliferation but did secrete the angiogenic growth factors vascular endothelial growth fa
150 jection of plasmid DNA encoding the secreted angiogenic growth factor, vascular endothelial growth fa
151 ine-hyaluronic acid hydrogel loaded with the angiogenic growth factor, vascular endothelial growth fa
152                     We hypothesized that the angiogenic growth factor, vascular endothelial growth fa
153 ctivity, resulting in high expression of pro-angiogenic growth factors: vascular endothelial growth f
154 s IL (interleukin)-10 and TGF-beta1, and the angiogenic growth factor VEGF (vascular endothelial grow
155 of the anti-inflammatory cytokine IL-10, the angiogenic growth factor VEGF and angiogenesis were high
156                                          The angiogenic growth factor VEGF generated by the inflamed
157 ng are well studied and are dependent on the angiogenic growth factor VEGF, the factors involved in s
158 ear polarity and migration downstream of the angiogenic growth factors VEGF-A and Slit2.
159 e cat retina in association with increase of angiogenic growth factors (VEGF and bFGF) and activation
160        Treatment of ECV 304 cells with known angiogenic growth factors (VEGF, bFGF, or hepatocyte gro
161  constitutive and TNF-mediated expression of angiogenic growth factors (VEGF, HGF, PLGF), and SDF-1al
162                 Cross-talk between the major angiogenic growth factor, VEGF, and integrin cell adhesi
163                 Injection of PR39 or another angiogenic growth factor, VEGF-B, into murine hearts dur
164 though VEGF165 is one of the most potent pro-angiogenic growth factors, VEGF165 treatment for myocard
165 e of vascular endothelial cells, bind to the angiogenic growth factor VEGFA to modulate its signaling
166 e upregulation of the downstream pathway and angiogenic growth factors via NFkappaB can be inferred t
167  CD13/APN in endothelial cells is induced by angiogenic growth factors via the RAS/MAPK pathway.
168 d with enhanced EC migration and response to angiogenic growth factors, we characterized a specific p
169 ting EPC numbers as well as plasma levels of angiogenic growth factors were assessed.
170 1) activates transcription of genes encoding angiogenic growth factors, which are secreted by hypoxic
171 ntal gradient of oxygen generates changes in angiogenic growth factors, which may underline the patho
172 RP1, NRP2) are receptors for semaphorins and angiogenic growth factors, while the GAIP interacting pr
173 ed sexually dimorphic associations of plasma angiogenic growth factors with brain aging outcomes, inc

 
Page Top